2019
DOI: 10.3389/fimmu.2019.00509
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus

Abstract: Bacterial infections are frequent and severe in patients with diabetes mellitus. Whether diabetes per se induces functional alterations in the complement system hampering activation during infection is unknown. We investigated key elements of the complement system during bacterial infections in patients with type 2 diabetes mellitus (T2DM) and compared them to non-diabetic (ND) individuals. Using a prospective design, we included 197 T2DM, and 196 ND subjects, all with clinical diagnosis of acute community-acq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 55 publications
0
15
0
1
Order By: Relevance
“…Ficolin-3 was furthermore identified to be deiminated in whole alligator plasma only and is a sugar pattern recognition molecule, which forms part of mammalian immune systems (132). Ficolin-3 can activate the complement system via the lectin pathway (133), plays roles in bacterial defenses (134,135) and autoimmunity (136,137) and is modulated in viral infections including HIV (138). Ficolin-3 has been associated with metabolic diseases including gestational, prediabetes, and type 2 diabetes (139,140), and identified as biomarkers in axial spondyloarthritis (141) and as a prognostic biomarker for esophageal cancer (142).…”
Section: Discussionmentioning
confidence: 99%
“…Ficolin-3 was furthermore identified to be deiminated in whole alligator plasma only and is a sugar pattern recognition molecule, which forms part of mammalian immune systems (132). Ficolin-3 can activate the complement system via the lectin pathway (133), plays roles in bacterial defenses (134,135) and autoimmunity (136,137) and is modulated in viral infections including HIV (138). Ficolin-3 has been associated with metabolic diseases including gestational, prediabetes, and type 2 diabetes (139,140), and identified as biomarkers in axial spondyloarthritis (141) and as a prognostic biomarker for esophageal cancer (142).…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, Barkai et al did not find significant differences in the function of classical or MBL pathways between T2DM and healthy individuals (130). However, significantly decreased activity of ficolin-3-mediated lectin and alternative pathways, as well as decreased levels of C4d and soluble complement C5b-9 (sC5b-9) were seen in diabetic patients with Escherichia coli-mediated urinary tract infections (130). This may be linked to a reduced ability of diabetics to protect themselves against bacterial infections.…”
Section: Innate Immunitymentioning
confidence: 92%
“…Reduced binding of MBL in the presence of high levels of sugar causes a significant reduction in the lectin pathway activity, but does not influence classical or alternative pathway activity (129). Nevertheless, Barkai et al did not find significant differences in the function of classical or MBL pathways between T2DM and healthy individuals (130). However, significantly decreased activity of ficolin-3-mediated lectin and alternative pathways, as well as decreased levels of C4d and soluble complement C5b-9 (sC5b-9) were seen in diabetic patients with Escherichia coli-mediated urinary tract infections (130).…”
Section: Innate Immunitymentioning
confidence: 97%
“…Enriched genes such as CCR2 [56], CCL19 [57], CX3CL1 [58], CXCL12 [59], IL20 [60], epidermal growth factor receptor (EGFR) [61], ERBB3 [62], adrenomedullin (ADM) [63], SCUBE1 [64], LMAN1L [65] and EGFL7 [66] were responsible for pathogenesis of CAD. Enriched genes such as CXCL6 [67], BMP7 [68], RXFP2 [69], BRS3 [70], FFAR3 [71], neuropeptide B (NPB) [72], SPON2 [73], FCN3 [74], REG3A [75] and ornithine carbamoyltransferase (OTC) [76] were culpable for pathogenesis of diabetes, but these genes may be involved in development of CAD. Enriched genes such as COL18A1 [77], cortistatin (CORT) [78], guanine nucleotide binding protein (G protein) [79] and MUC2 [80] were involved in development of obesity, but these genes may be associated with pathogenesis of CAD.…”
Section: Discussionmentioning
confidence: 99%